checkAd
    Startseite > Aktien > Aspira Women's Health > Nachrichten
    Aspira Women's Health Aktie
    0,2570
     
    USD
    0,00 %
    0,0000 USD
    Letzter Kurs 12.05.23 Nasdaq
    0,2673
     
    USD
    300 STK
    Geldkurs 11.05.23
    0,2700
     
    USD
    50.000 STK
    Briefkurs 11.05.23
    ISIN: US04537Y1091 · WKN: A2P6V3 · SYM: AWH · USA

    Neueste Nachrichten

    Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California
    09.04.24 · globenewswire · Aspira Women's Health
    Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results
    28.03.24 · globenewswire · Aspira Women's Health
    Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call
    25.03.24 · globenewswire · Aspira Women's Health
    Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor Conference
    21.03.24 · globenewswire · Aspira Women's Health
    Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President
    18.03.24 · globenewswire · Aspira Women's Health
    Aspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024
    11.03.24 · globenewswire · Aspira Women's Health
    Aspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference
    22.02.24 · globenewswire · Aspira Women's Health
    Aspira Women’s Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI)
    12.02.24 · globenewswire · Aspira Women's Health
    Aspira Women’s Health Announces OvaSuite(SM) Distribution Agreement in the Philippines
    06.02.24 · globenewswire · Aspira Women's Health
    Aspira Women’s Health Announces $5.5 Million Registered Direct Offering and Concurrent Private Placement
    25.01.24 · globenewswire · Aspira Women's Health
    Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024
    19.12.23 · globenewswire · Aspira Women's Health
    Aspira Women’s Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal)
    28.11.23 · globenewswire · Aspira Women's Health